197 filings
Page 6 of 10
6-K
21lvi
27 Aug 18
Current report (foreign)
12:00am
6-K
j25i5 gthqd51zz
8 Aug 18
Index to Condensed Consolidated Financial Statements
7:30am
6-K
54al79z ww7821uv
20 Jun 18
Current report (foreign)
4:15pm
6-K
atmtd62ft s07j
15 Jun 18
Current report (foreign)
12:00am
6-K
5pj yfuwk
18 May 18
Affimed Announces Annual General Meeting of Shareholders
4:17pm
6-K
su6wv9
15 May 18
Index to Condensed Consolidated Financial Statements
7:48am
6-K
tm8pxk
20 Mar 18
Affimed Reports Financial Results for Fourth Quarter
12:00am
6-K
yhkx0zvaxyhy
8 Mar 18
Transforming Immuno - Oncology Using Next - Generation Immune Cell Engagers Corporate Presentation March 2018
12:00am
6-K
a9cai88mrd
15 Feb 18
Current report (foreign)
12:00am
424B5
am3rh6v386loq
14 Feb 18
Prospectus supplement for primary offering
12:00am
424B5
kok3ah9 qtu2lx
12 Feb 18
Prospectus supplement for primary offering
12:00am
6-K
lzjqj78r3 gsm
1 Feb 18
Affimed Reports New Data for AFM13 from Two Separate Clinical Trials in Hodgkin and CD30-Positive Lymphomas
12:00am
6-K
84wdterwhf8t1go3i
5 Jan 18
Transforming Immuno - Oncology Using Next - Generation Immune Cell Engagers Corporate Presentation January 2018
12:00am
6-K
toyzxwkn
7 Nov 17
Index to Condensed Consolidated Financial Statements
12:00am
6-K
pr2hzr
13 Sep 17
Affimed Appoints Dr. Wolfgang Fischer as Chief Operating Officer
12:00am
6-K
m1yz 48ywwu4
1 Aug 17
Index to Condensed Consolidated Financial Statements
12:00am
6-K
tmlu4prtjy3ddyu
21 Jun 17
Current report (foreign)
12:00am
6-K
fxuh7 15opvn58pbaoi8
22 May 17
Affimed Announces Annual General Meeting of Shareholders
12:00am
6-K
3oksrm
17 May 17
Index to Condensed Consolidated Financial Statements
12:00am